REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2015 13F Holders as of 6/30/2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
170
Total 13F shares, excl. options
29.8M
Shares change
+896K
Total reported value, excl. options
$1.23B
Value change
+$44.4M
Put/Call ratio
0.41
Number of buys
79
Number of sells
-90
Price
$41.27

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2015

196 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2015.
REPLIGEN CORP - COMMON STOCK (RGEN) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29.8M shares of 56.2M outstanding shares and own 53.01% of the company stock.
Largest 10 shareholders include FMR LLC (3.66M shares), BlackRock Fund Advisors (2.24M shares), Invesco Ltd. (1.89M shares), RS INVESTMENT MANAGEMENT CO LLC (1.38M shares), OPPENHEIMER FUNDS INC (1.33M shares), STATE STREET CORP (1.27M shares), VANGUARD GROUP INC (1.27M shares), DIMENSIONAL FUND ADVISORS LP (1.23M shares), RENAISSANCE TECHNOLOGIES LLC (950K shares), and BlackRock Institutional Trust Company, N.A. (916K shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.